Efflux pump inhibitors function by binding to the efflux pumps and preventing them from extruding drugs out of the cancer cells. By inhibiting these pumps, the intracellular concentration of chemotherapeutic agents increases, which can lead to improved cytotoxic effects against cancer cells.
